Skip to main content
. Author manuscript; available in PMC: 2010 Nov 9.
Published in final edited form as: Pharmacogenet Genomics. 2009 Oct;19(10):770–780. doi: 10.1097/FPC.0b013e328330eeca

Table 3.

Oligonucleotide primers used in the construction of MATE1 reporter plasmids or AP-2rep plasmid and the electrophoretic mobility shift analysis

Primers for MATE1 promoter sequencing
  Sense 5’-GGG AGC ATG TTG CTC TAT CC-3’
  Antisense 5’-AGG AGC TTC CAT GTG ACT CG-3’
Primers for MATE1 promoter cloning
  First PCR (−543 to +15)
 Sense 5’-AGT ATG CAA CAC CCT AAC CAG CA-3’
 Antisense 5’-CCT CAG GAG CTT CCA TGT GAC T-3’
  Second PCR (−234 to −12)
 Sense (NheI site)1 5’-CTA GCT AGC GGT GCA GAG AGA GGT GCA A-3’
 Antisense (HindIII site)1 5’-CCC AAG CTT GCT GCG GCC GGG TAG-3’

  Primers for AP-2rep cloning
 Sense (NheI site)1 5’-GCT AGC ATG AAT ATC CAT ATG AAG AGA-3’
 Antisense (KpnI site)1 5’-GGT ACC GCT GGA CAG GTA GCA TTC CTC AC-3’

  Primers for EMSA
 Reference (g.−66T)2 5’-TGC GCG GTA CTC ACT GCC GGC C-3’
 Variant (g.−66C)2 5’-TGC GCG GTA CCC ACT GCC GGC C-3’
 Consensus AP-13 5’-AAG CCT GTG ACT CAG GAC CTG-3’
 Consensus AP-2rep4 5’-CTG GGG CAG TGG GAC TGG CA-3’
1

The restriction endonuclease sites are marked by bold-faced letters.

2

The SNP sites are marked by bold-faced letters.

3,4

The consensus sequences of AP-1 and AP-2rep are marked by bold-faced letters [15, 25].